Works by Yi, Ka Hee


Results: 50
    1

    The Korean guideline for thyroid cancer screening.

    Published in:
    Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi, 2015, v. 58, n. 4, p. 302, doi. 10.5124/jkma.2015.58.4.302
    By:
    • Ka Hee Yi;
    • Soo Young Kim;
    • Do Hoon Kim;
    • Sun Wook Kim;
    • Dong Gyu Na;
    • You Jin Lee;
    • Ki Wook Chung;
    • Kui Son Choi;
    • Yoon Woo Koh;
    • Won Bae Kim;
    • Kee-Hyun Nam;
    • Seung-Kuk Baek;
    • Jung Hwan Baek;
    • Soon Young Lee;
    • Yuh Seok Jung;
    • Jung Jin Cho;
    • Young-Su Ju;
    • Ji Yeon Dang;
    • Yeol Kim;
    • Won-Chul Lee
    Publication type:
    Article
    2
    3
    4
    5

    Longitudinal Assessment of Quality of Life According to Treatment Options in Low-Risk Papillary Thyroid Microcarcinoma Patients: Active Surveillance or Immediate Surgery (Interim Analysis of MAeSTro).

    Published in:
    Thyroid, 2019, v. 29, n. 8, p. 1089, doi. 10.1089/thy.2018.0624
    By:
    • Kong, Sung Hye;
    • Ryu, Junsun;
    • Kim, Min Joo;
    • Cho, Sun Wook;
    • Song, Young Shin;
    • Yi, Ka Hee;
    • Park, Do Joon;
    • Hwangbo, Yul;
    • Lee, You Jin;
    • Lee, Kyu Eun;
    • Kim, Su-jin;
    • Jeong, Woo-Jin;
    • Chung, Eun-Jae;
    • Hah, Jeong Hun;
    • Choi, June Young;
    • Ryu, Chang Hwan;
    • Jung, Yuh-Seog;
    • Moon, Jae Hoon;
    • Lee, Eun Kyung;
    • Park, Young Joo
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Antithyroid drug therapy for Graves' disease.

    Published in:
    Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi, 2021, v. 64, n. 10, p. 690, doi. 10.5124/jkma.2021.64.10.690
    By:
    • Soo Myoung Shin;
    • Ka Hee Yi
    Publication type:
    Article
    12
    13

    Recombinant human thyrotropin-stimulated thyroglobulin level at the time of radioactive iodine ablation is an independent prognostic marker of differentiated thyroid carcinoma in the setting of prophylactic central neck dissection.

    Published in:
    Clinical Endocrinology, 2016, v. 85, n. 3, p. 459, doi. 10.1111/cen.13029
    By:
    • Moon, Jae Hoon;
    • Choi, June Young;
    • Jeong, Woo‐Jin;
    • Ahn, Soon‐Hyun;
    • Lee, Won Woo;
    • Kim, Kyoung Min;
    • Choi, Sung Hee;
    • Lim, Soo;
    • Park, Young Joo;
    • Yi, Ka Hee;
    • Park, Do Joon;
    • Jang, Hak Chul
    Publication type:
    Article
    14

    Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years.

    Published in:
    Clinical Endocrinology, 2016, v. 84, n. 4, p. 587, doi. 10.1111/cen.12852
    By:
    • Jung, Kyong Yeun;
    • Kim, Seok‐Mo;
    • Yoo, Won Sang;
    • Kim, Bup‐Woo;
    • Lee, Yong Sang;
    • Kim, Kyung Won;
    • Lee, Kyu Eun;
    • Jeong, Jong Ju;
    • Nam, Kee‐Hyun;
    • Lee, Se Hoon;
    • Hah, Jeong Hun;
    • Chung, Woong Youn;
    • Yi, Ka Hee;
    • Park, Do Joon;
    • Youn, Yeo‐Kyu;
    • Sung, Myung‐Whun;
    • Cho, Bo Youn;
    • Park, Cheong Soo;
    • Park, Young Joo;
    • Chang, Hang‐Seok
    Publication type:
    Article
    15
    16
    17
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Prognostic factors for Korean patients with anaplastic thyroid carcinoma.

    Published in:
    Head & Neck, 2007, v. 29, n. 8, p. 765, doi. 10.1002/hed.20578
    By:
    • Tae Yong Kim;
    • Kyung Won Kim;
    • Tae Sik Jung;
    • Jung Min Kim;
    • Sun Wook Kim;
    • Ki-Wook Chung;
    • Eun Young Kim;
    • Gyungyub Gong;
    • Young Lyun Oh;
    • Soo Youn Cho;
    • Ka Hee Yi;
    • Won Bae Kim;
    • Park, Do Joon;
    • Jae Hoon Chung;
    • Bo Youn Cho;
    • Young Kee Shong
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41

    A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol.

    Published in:
    Endocrinology & Metabolism, 2021, v. 36, n. 3, p. 574, doi. 10.3803/EnM.2020.943
    By:
    • Eun Kyung Lee;
    • Yea Eun Kang;
    • Young Joo Park;
    • Bon Seok Koo;
    • Ki-Wook Chung;
    • Eu Jeong Ku;
    • Ho-Ryun Won;
    • Won Sang Yoo;
    • Eonju Jeon;
    • Se Hyun Paek;
    • Yong Sang Lee;
    • Dong Mee Lim;
    • Yong Joon Suh;
    • Ha Kyoung Park;
    • Hyo-Jeong Kim;
    • Bo Hyun Kim;
    • Mijin Kim;
    • Sun Wook Kim;
    • Ka Hee Yi;
    • Park, Sue K.
    Publication type:
    Article
    42

    A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol

    Published in:
    Endocrinology & Metabolism, 2020, v. 35, n. 3, p. 571, doi. 10.3803/EnM.2020.681
    By:
    • Eun Kyung Lee;
    • You Jin Lee;
    • Young Joo Park;
    • Jae Hoon Moon;
    • Ka Hee Yi;
    • Koon Soon Kim;
    • Joo Hee Lee;
    • Sun Wook Cho;
    • Jungnam Joo;
    • Yul Hwangbo;
    • Sujeong Go;
    • Do Joon Park
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50